Receptor for Plasmin on Human Carcinoma Cells1
- 20 July 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 80 (10) , 762-765
- https://doi.org/10.1093/jnci/80.10.762
Abstract
We have shown that cells from human tumor cell line SW 1116 have receptors for plasmin and plasminogen. These receptors are the same for the proenzyme and the enzyme, but they have a much higher affinity for plasmin (Kd = 6 × 10−8M) than for plasminogen (Kd = 5 × 10−6M). Plasminogen binding was strongly increased by preincubation of the tumor cells with urokinase and was inhibited by anti-urokinase serum. Because free plasmin is rapidly neutralized in vivo, it is likely that, under physiological conditions, plasminogen is bound by tumor cells and partially transformed into plasmin by urokinase already present at the surface of these cells. Bound plasmin retains its enzymatic activity, which demonstrates that its binding does not involve the enzyme's active site. [J Natl Cancer Inst 1988;80:762–765]This publication has 10 references indexed in Scilit:
- The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence studyInternational Journal of Cancer, 1987
- The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.The Journal of cell biology, 1986
- Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I.Proceedings of the National Academy of Sciences, 1986
- Binding and activation of plasminogen on the platelet surface.Journal of Biological Chemistry, 1985
- The plasmin system in human colonic tumors: An immunofluorescence studyInternational Journal of Cancer, 1985
- A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.The Journal of cell biology, 1985
- Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasisInternational Journal of Cancer, 1982
- Plasminogen Activator Released as Inactive Proenzyme from Murine Cells Transformed by Sarcoma VirusEuropean Journal of Biochemistry, 1982
- EFFECT OF PLASMINOGEN-ACTIVATOR (UROKINASE), PLASMIN, AND THROMBIN ON GLYCOPROTEIN AND COLLAGENOUS COMPONENTS OF BASEMENT-MEMBRANE1981
- Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cellsCell, 1980